kTMP in Chronic Stroke
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorUniversity of California, San Francisco
About this trial
kTMP, kilohertz transcutaneous magnetic perturbations, is a low intensity transcranial magnetic stimulation technique that will be used in this study to promote arm/hand rehabilitation in patients who have been disabled by stroke.
Eligibility criteria
Qualifiers
Adults age 18-80 years old who have had a stroke resulting in hemiplegia
Ability to communicate, understand, and give appropriate consent
Other criteria may apply
Disqualifiers
Significant cognitive impairment
inability to adhere to the study protocol or provide informed consent
pregnancy
additional criteria may apply
Trial design
Treatments tested in this trial
- kTMP sham stimulation 9 weeks + active stimulation 9 weeks
- kTMP 18 weeks
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of California, San Francisco
Lead sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator
Source ClinicalTrials.gov